Popular on TelAve
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- The ITeam Ranked on Channel Partners 2025 MSP 501—Tech Industry's Most Prestigious List of Managed Service Providers Worldwide
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Keepy Uppy™ by Ollyball Wins Prestigious 2025 Influencer Award from Clamour & The Toy Association; Announces Fall 2025 Launch at Target Stores
- databahn Launches GenAI Sales Intelligence Platform to Revolutionize Fortune 500 and Global 2000 Account Research
- TCAA Welcomes Adolfo Gomez Sanchez to Its Family of Talented Speakers
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Honoring Black History, Culture, and Community in Fall River
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
Similar on TelAve
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Mensa Foundation Prize Awarded to Neuroscientist-Pianist
- Global Court Momentum Builds Against Forced Psychiatry; CCHR Urges U.S. Reform
- Urgent Reform Demanded to Stop Child Abuse in Youth Behavioral Facilities
- CCHR Warns: Millions of Children Exposed to Risky Psychiatric Drugs
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
Autonomous detection of AI hallucinations in digital pathology
TelAve News/10866208
LOS ANGELES - TelAve -- Tissue staining is a cornerstone of medical diagnostics, used to highlight cellular structures and render tissue features visible under an optical microscope—critical for identifying diseases such as cancer. Traditionally, this process involves applying chemical dyes, like hematoxylin and eosin (H&E), to thinly sliced tissue samples. While effective, it is time-consuming, destructive, and resource-intensive. Virtual staining, powered by AI, offers a transformative alternative by digitally generating the equivalent of histochemically stained images from label-free autofluorescence microscopy data. This computational approach enables faster, more cost-effective, and scalable diagnostics without the need for physical dyes, while also preserving the tissue sample for further analysis. However, like other generative AI models, virtual staining carries the risk of hallucinations—errors where the AI adds or alters microscopic tissue features that are not present in the actual specimen. When these hallucinations appear realistic, they can mislead even experienced pathologists, jeopardizing diagnostic accuracy.
More on TelAve News
To address this challenge, a team led by Professor Aydogan Ozcan at the University of California, Los Angeles (UCLA), in collaboration with pathologists from the University of Southern California and Hadassah Hebrew University Medical Center, developed an autonomous image quality assessment tool for detecting hallucinations in virtual staining and digital pathology. Named AQuA (Autonomous Quality Assessment), this AI-powered tool autonomously detects subtle hallucinations in digitally stained tissue slides—without requiring histochemical ground truth for comparison—and outperforms human experts in identifying potentially misleading tissue image artifacts.
Published in Nature Biomedical Engineering, AQuA operates independently of the original AI staining model and does not rely on paired histochemically stained images. It uses iterative image translation cycles between the H&E and autofluorescence domains, which amplify even subtle inconsistencies. These cycles produce sequences of images that are rapidly evaluated by an ensemble of neural networks—effectively a panel of digital judges—to determine image quality and flag hallucinations before the images reach pathologists. This architecture makes AQuA fast, adaptable, and scalable across different tissue types, staining styles, and pathology applications.
More on TelAve News
In extensive testing on human kidney and lung biopsy samples, AQuA achieved 99.8% and 97.8% accuracy, respectively, in distinguishing high-quality from low-quality virtually stained images—all without access to the original histochemically stained tissue images or the AI model used to generate the virtually stained counterparts. It also showed over 98% agreement with board-certified pathologists and, in some cases, outperformed them—especially in detecting realistic-looking hallucinations that experts missed when ground truth staining was unavailable. Beyond virtual staining, the researchers demonstrated that AQuA could also assess the quality of conventional chemically stained tissue slides, automatically detecting common staining artifacts in clinical workflows.
Paper: https://www.nature.com/articles/s41551-025-01421-9
More on TelAve News
- Revolutionary Blockchain Platform Okh Finance Announces Okh Finance(OKKH) Token Launch to Transform Global Asset Leasing Market
- Cover Girl Finalist Teisha Mechetti Questions Legitimacy of Inked Originals Competition, Demands Transparency
- Easton & Easton, LLP Files Suit Against The Dwelling Place Anaheim & Vineyard USA Over Abuse Allegations
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
To address this challenge, a team led by Professor Aydogan Ozcan at the University of California, Los Angeles (UCLA), in collaboration with pathologists from the University of Southern California and Hadassah Hebrew University Medical Center, developed an autonomous image quality assessment tool for detecting hallucinations in virtual staining and digital pathology. Named AQuA (Autonomous Quality Assessment), this AI-powered tool autonomously detects subtle hallucinations in digitally stained tissue slides—without requiring histochemical ground truth for comparison—and outperforms human experts in identifying potentially misleading tissue image artifacts.
Published in Nature Biomedical Engineering, AQuA operates independently of the original AI staining model and does not rely on paired histochemically stained images. It uses iterative image translation cycles between the H&E and autofluorescence domains, which amplify even subtle inconsistencies. These cycles produce sequences of images that are rapidly evaluated by an ensemble of neural networks—effectively a panel of digital judges—to determine image quality and flag hallucinations before the images reach pathologists. This architecture makes AQuA fast, adaptable, and scalable across different tissue types, staining styles, and pathology applications.
More on TelAve News
- Colbert Packaging Announces WBENC Recognition
- DivX Empowers Media Enthusiasts with Free Expert Guides for Advanced MP4 Management
- Assent Expands Executive Team to Accelerate Global Growth & Innovation
- The World's Largest Green Economic Revolution Emerges as Nature, Tech, and Finance Converge
- Vinnetwork Unveils Decentralized AI Platform with Vinnetwork(VIN) Token to Challenge Tech Giants' Data Monopoly
In extensive testing on human kidney and lung biopsy samples, AQuA achieved 99.8% and 97.8% accuracy, respectively, in distinguishing high-quality from low-quality virtually stained images—all without access to the original histochemically stained tissue images or the AI model used to generate the virtually stained counterparts. It also showed over 98% agreement with board-certified pathologists and, in some cases, outperformed them—especially in detecting realistic-looking hallucinations that experts missed when ground truth staining was unavailable. Beyond virtual staining, the researchers demonstrated that AQuA could also assess the quality of conventional chemically stained tissue slides, automatically detecting common staining artifacts in clinical workflows.
Paper: https://www.nature.com/articles/s41551-025-01421-9
Source: ucla ita
0 Comments
Latest on TelAve News
- Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
- Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
- Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
- Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm
- Vertical Consultants Launches Interactive Lease Grader Tool for Cell Tower Property Owners
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild